Raymond James Financial Inc Vaxart, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Vaxart, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 236,166 shares of VXRT stock, worth $89,743. This represents 0.0% of its overall portfolio holdings.
Number of Shares
236,166
Previous 202,091
16.86%
Holding current value
$89,743
Previous $82,000
29.27%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding VXRT
# of Institutions
105Shares Held
23.1MCall Options Held
50.3KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA10.4MShares$3.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.33MShares$884,0200.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$674,2510.0% of portfolio
-
Marshall Wace, LLP London, X01.76MShares$670,2750.0% of portfolio
-
State Street Corp Boston, MA851KShares$323,4250.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $48.1M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...